Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Brotherick

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Surgical Oncology|August 1, 1993
Production of immunosuppressive factors by a cultured tumour cell line and their effect on lymphocyte proliferation and cell cycle responseI Brotherick, B K Shenton, J A Kirby, et al.
Cancer Immunology, Immunotherapy : CII|September 1, 1995
p53 expression measured by flow cytometry. A comparison of three monoclonal antibodies and the relationship with grade and DNA ploidy in breast cancerI Brotherick, B K Shenton, W K Cowan, et al.
Oncology|January 14, 1999
Cyclin D3 expression, cell proliferation and pathological stage of human primary colorectal cancerD S Watson, I Brotherick, B K Shenton, et al.
Cytometry|October 13, 2001
Use of the monoclonal antibody DAKO-ERbeta (8D5-1) to measure oestrogen receptor beta in breast cancer cellsF Girdler, D A Browell, W J Cunliffe, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1996
Examination of multidrug resistance in cell lines and primary breast tumours by flow cytometryI Brotherick, B K Shenton, M Egan, et al.
British Journal of Cancer|July 4, 1998
The effect of 3-week tamoxifen treatment on oestrogen receptor levels in primary breast tumours: a flow cytometric studyI Brotherick, D A Browell, B K Shenton, et al.
British Journal of Cancer|August 1, 1996
Cell adhesion molecules in bladder cancer: soluble serum E-cadherin correlates with predictors of recurrenceT R Griffiths, I Brotherick, R I Bishop, et al.
Breast Cancer Research and Treatment|September 20, 2001
MUC1 expression in primary breast cancer: the effect of tamoxifen treatmentJ M Hanson, D A BroweIl, W J Cunliffe, et al.
Cytometry|August 13, 1998
Cytokeratin expression in breast cancer: phenotypic changes associated with disease progressionI Brotherick, C N Robson, D A Browell, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Surgical Oncology|August 1, 1993
Production of immunosuppressive factors by a cultured tumour cell line and their effect on lymphocyte proliferation and cell cycle responseI Brotherick, B K Shenton, J A Kirby, et al.
Cancer Immunology, Immunotherapy : CII|September 1, 1995
p53 expression measured by flow cytometry. A comparison of three monoclonal antibodies and the relationship with grade and DNA ploidy in breast cancerI Brotherick, B K Shenton, W K Cowan, et al.
Oncology|January 14, 1999
Cyclin D3 expression, cell proliferation and pathological stage of human primary colorectal cancerD S Watson, I Brotherick, B K Shenton, et al.
Cytometry|October 13, 2001
Use of the monoclonal antibody DAKO-ERbeta (8D5-1) to measure oestrogen receptor beta in breast cancer cellsF Girdler, D A Browell, W J Cunliffe, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1996
Examination of multidrug resistance in cell lines and primary breast tumours by flow cytometryI Brotherick, B K Shenton, M Egan, et al.
British Journal of Cancer|July 4, 1998
The effect of 3-week tamoxifen treatment on oestrogen receptor levels in primary breast tumours: a flow cytometric studyI Brotherick, D A Browell, B K Shenton, et al.
British Journal of Cancer|August 1, 1996
Cell adhesion molecules in bladder cancer: soluble serum E-cadherin correlates with predictors of recurrenceT R Griffiths, I Brotherick, R I Bishop, et al.
Breast Cancer Research and Treatment|September 20, 2001
MUC1 expression in primary breast cancer: the effect of tamoxifen treatmentJ M Hanson, D A BroweIl, W J Cunliffe, et al.
Cytometry|August 13, 1998
Cytokeratin expression in breast cancer: phenotypic changes associated with disease progressionI Brotherick, C N Robson, D A Browell, et al.
Pageof 2